{
    "name": "retapamulin",
    "comment": "Rx",
    "other_names": [
        "Altabax"
    ],
    "classes": [
        "Antibacterials",
        "Topical",
        "Pleuromutilins"
    ],
    "source": "https://reference.medscape.com/drug/altabax-retapamulin-topical-343481",
    "pregnancy": {
        "common": [
            "There are no available data on use in pregnant women to inform any drug associated risk for major birth defects, miscarriage or adverse maternal or fetal outcomes; drug is negligibly absorbed systemically following topical administration and maternal use is not expected to result in fetal exposure"
        ],
        "specific": [
            {
                "type": "Animal data",
                "description": [
                    "Animal reproduction studies were not conducted with drug; however, in animal studies where drug was administered by oral gavage or intravenous infusion to pregnant rats and rabbits, respectively, during organogenesis, maternal toxicity was seen at doses ≥150 mg/kg/day and 7.2 mg/kg/day (8-fold the maximum achievable human exposure based on AUC) for oral and intravenous routes, respectively"
                ]
            }
        ]
    },
    "lactation": {
        "common": [
            "There are no data available on presence of drug in human milk, its effects on breastfed infant or on milk production; however, breastfeeding is not expected to result in exposure of child to drug due to negligible systemic absorption in humans following topical administration of drug",
            "Developmental and health benefits of breastfeeding should be considered along with mother’s clinical need for therapy and any potential adverse effects on breastfed infant from drug or from underlying maternal condition"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "None"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Not for oral, intranasal, ophthalmic or intravaginal use; efficacy and safety for mucosal surfaces not established",
                "Discontinue if sensitization or severe local irritation develops",
                "Epistaxis reported with use on nasal mucosa",
                "Not evaluated on mucosal surfaces"
            ],
            "specific": []
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Application site irritation",
            "percent": "2"
        }
    ]
}